The US Multi-Society Task Force on Colorectal Cancer provides 14 recommendations for the genetic evaluation, surveillance, and treatment of gastrointestinal hamartomatous polyposis syndromes.
With new data in hand, the US Preventive Services Task Force has shied away from its previous recommendation for low-dose aspirin to prevent colorectal cancer.
The Task Force advises against starting aspirin for primary prevention in people aged 60 years or over and suggests the decision should be individualized in those aged 40-59.
Experts call for nuanced prescribing of proton pump inhibitors to patients with cirrhosis in a study that found lower mortality only in those with gastrointestinal bleeding.